BIT
VRTX icon

BlackRock Institutional Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

BlackRock Institutional Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$481M Buy
6,532,503
+40,282
+0.6% +$3.28M 0.07% 275
2016
Q3 		$566M Buy
6,492,221
+144,397
+2% +$13.6M 0.09% 237
2016
Q2 		$546M Buy
6,347,824
+9,670
+0.2% +$836K 0.09% 237
2016
Q1 		$504M Buy
6,338,154
+86,478
+1% +$7.82M 0.08% 242
2015
Q4 		$787M Buy
6,251,676
+81,517
+1% +$9.84M 0.13% 153
2015
Q3 		$643M Sell
6,170,159
-214,196
-3% -$27.5M 0.11% 186
2015
Q2 		$788M Sell
6,384,355
-76,522
-1% -$9.64M 0.13% 160
2015
Q1 		$762M Buy
6,460,877
+144,910
+2% +$17.4M 0.12% 178
2014
Q4 		$750M Buy
6,315,967
+124,032
+2% +$14M 0.12% 177
2014
Q3 		$695M Buy
6,191,935
+129,338
+2% +$12.3M 0.12% 177
2014
Q2 		$574M Buy
6,062,597
+28,401
+0.5% +$1.99M 0.1% 217
2014
Q1 		$427M Buy
6,034,196
+46,187
+0.8% +$3.66M 0.07% 257
2013
Q4 		$445M Sell
5,988,009
-97,492
-2% -$6.79M 0.08% 241
2013
Q3 		$461M Buy
6,085,501
+249,358
+4% +$19.8M 0.09% 224
2013
Q2 		$467M Buy
+5,836,143
New +$430M 0.09% 214

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust's VRTX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Vertex Pharmaceuticals (VRTX) stake by 0.62% in Q4 2016, buying an estimated $3.28M and bringing the position to 6,532,503 shares worth $481M. The position accounts for 0.07% of the portfolio, ranked #275.

BlackRock Institutional Trust first reported a position in VRTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $788M in Q2 2015. 483 funds tracked by Wall St. Rank hold VRTX as of Q4 2016.

  • BlackRock Institutional Trust held 6,532,503 shares of Vertex Pharmaceuticals worth $481M as of Q4 2016.
  • BlackRock Institutional Trust bought 40,282 Vertex Pharmaceuticals shares in Q4 2016, an estimated $3.28M.
  • Vertex Pharmaceuticals made up 0.07% of BlackRock Institutional Trust's portfolio in Q4 2016, its #275 holding.
  • BlackRock Institutional Trust first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Vertex Pharmaceuticals position peaked at $788M in Q2 2015.
  • 483 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.